Literature DB >> 7962191

Talin, vinculin and DRP (utrophin) concentrations are increased at mdx myotendinous junctions following onset of necrosis.

D J Law1, D L Allen, J G Tidball.   

Abstract

Duchenne muscular dystrophy (DMD) and the myopathy seen in the mdx mouse both result from absence of the protein dystrophin. Structural similarities between dystrophin and other cytoskeletal proteins, its enrichment at myotendinous junctions, and its indirect association with laminin mediated by a transmembrane glycoprotein complex suggest that one of dystrophin's functions in normal muscle is to form one of the links between the actin cytoskeleton and the extracellular matrix. Unlike Duchenne muscular dystrophy patients, mdx mice suffer only transient muscle necrosis, and are able to regenerate damaged muscle tissue. The present study tests the hypothesis that mdx mice partially compensate for dystrophin's absence by upregulating one or more dystrophin-independent mechanisms of cytoskeleton-membrane association. Quantitative analysis of immunoblots of adult mdx muscle samples showed an increase of approximately 200% for vinculin and talin, cytoskeletal proteins that mediate thin filament-membrane interactions at myotendinous junctions. Blots also showed an increase (143%) in the dystrophin-related protein called utrophin, another myotendinous junction constituent, which may be able to substitute for dystrophin directly. Muscle samples from 2-week-old animals, a period immediately preceding the onset of muscle necrosis, showed no significant differences in protein concentration between mdx and controls. Quantitative analyses of confocal images of myotendinous junctions from mdx and control muscles show significantly higher concentrations of talin and vinculin at the myotendinous junctions of mdx muscle. These findings indicate that mdx mice may compensate in part for the absence of dystrophin by increased expression of other molecules that subsume dystrophin's mechanical function.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7962191     DOI: 10.1242/jcs.107.6.1477

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  33 in total

Review 1.  Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse.

Authors:  J M Gillis
Journal:  J Muscle Res Cell Motil       Date:  1999-10       Impact factor: 2.698

2.  The GTPase RhoA increases utrophin expression and stability, as well as its localization at the plasma membrane.

Authors:  Armelle Bonet-Kerrache; Mathieu Fortier; Franck Comunale; Cécile Gauthier-Rouvière
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

3.  Alterations in the proportions of skeletal muscle proteins following a unilateral lesion to the substantia nigra pars compacta of rats.

Authors:  A Sliwinski; D Stanic; D I Finkelstein; M Ilic; J M West; P C Dooley
Journal:  J Muscle Res Cell Motil       Date:  2005-07-01       Impact factor: 2.698

Review 4.  Immunobiology of Inherited Muscular Dystrophies.

Authors:  James G Tidball; Steven S Welc; Michelle Wehling-Henricks
Journal:  Compr Physiol       Date:  2018-09-14       Impact factor: 9.090

Review 5.  Integrin signaling: linking mechanical stimulation to skeletal muscle hypertrophy.

Authors:  Marni D Boppart; Ziad S Mahmassani
Journal:  Am J Physiol Cell Physiol       Date:  2019-07-17       Impact factor: 4.249

Review 6.  Porcine models of muscular dystrophy.

Authors:  Joshua T Selsby; Jason W Ross; Dan Nonneman; Katrin Hollinger
Journal:  ILAR J       Date:  2015

7.  Filamentous structures in skeletal muscle: anchors for the subsarcolemmal space.

Authors:  Astrid Feinisa Khairani; Yuki Tajika; Maiko Takahashi; Hitoshi Ueno; Tohru Murakami; Arifin Soenggono; Hiroshi Yorifuji
Journal:  Med Mol Morphol       Date:  2014-02-12       Impact factor: 2.309

8.  Cytoplasmic gamma-actin expression in diverse animal models of muscular dystrophy.

Authors:  Laurin M Hanft; Daniel J Bogan; Ulrike Mayer; Stephen J Kaufman; Joe N Kornegay; James M Ervasti
Journal:  Neuromuscul Disord       Date:  2007-05-01       Impact factor: 4.296

Review 9.  Vinculin and talin: focus on the myocardium.

Authors:  Alice Zemljic-Harpf; Ana Maria Manso; Robert S Ross
Journal:  J Investig Med       Date:  2009-12       Impact factor: 2.895

Review 10.  Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.

Authors:  Joe N Kornegay; Christopher F Spurney; Peter P Nghiem; Candice L Brinkmeyer-Langford; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  ILAR J       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.